CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 37,254 shares at an average $45.08 ($1,679,510)
- 4 Open-market sale Chief Financial Officer sold 20,236 shares at an average $45.02 ($910,947)
- 4 Open-market sale Chief Financial Officer sold 47,195 shares at $45.14 ($2,130,382)
- 8-K Event Results of operations · Regulation FD disclosure · Other events
- 4 Open-market sale President & CSO sold 53,729 shares at an average $37.46 ($2,012,490)
- 4 Option exercise President & CSO acquired 4,500 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale President & CSO sold 51,015 shares at an average $42.70 ($2,178,229)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale CEO sold 50,000 shares at an average $46.33 ($2,316,428)
- 4 Open-market sale 10% owner sold 551 shares at $54.25 ($29,892)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 16 of 26 · 514 filings